Evidence map›Paper›PMID 40732687›Full record

ArticlePathogens (Basel, Switzerland)2025

Emergence of Dengue Virus Serotypes 1 and 3 in Mahottari and Adjacent Areas of Southern Nepal.

Sabin Shrestha, Sandesh Rimal, Anjana Kharbuja, Manoj Kumar Ray, Susmita Shrestha, Anjali Dulal, Suprabha Subedi, Ashma Khadka, Nabaraj Adhikari, Meghnath Dhimal and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sabin ShresthaCentral Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.ORCID 0000-0002-9522-8547
Sandesh RimalCentral Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.ORCID 0000-0002-8064-3625
Anjana KharbujaCentral Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.
Manoj Kumar RayBardibas Hospital, Mahottari 45700, Nepal.
Susmita ShresthaShare and Care Medical Center Private Limited, Sunsari 56700, Nepal.
Anjali DulalCentral Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.
Suprabha SubediCentral Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.
Ashma KhadkaCentral Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.
Nabaraj AdhikariCentral Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.
Meghnath DhimalNepal Health Research Council, Ram Shah Path, Kathmandu 44600, Nepal.ORCID 0000-0001-7176-7821
Basu Dev PandeyDEJIMA Infectious Diseases Research Alliance, Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0001-7992-7586
Takeshi UranoCenter for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo 690-8504, Japan.
Kouichi MoritaDEJIMA Infectious Diseases Research Alliance, Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0001-8391-1157
Mya Myat Ngwe TunDEJIMA Infectious Diseases Research Alliance, Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0002-8986-6307
Shyam Prakash DumreCentral Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.ORCID 0000-0002-4072-0745

Funding

Japan Agency of Medical Research and Development JP253fa627004, 24jm0210114h0001
6 · The paper itself

Abstract

Dengue has been a serious public health concern in Nepal since the past few years, with concurrent big outbreaks occurring in 2022-2024. This cross-sectional study was conducted among febrile patients visiting hospitals in Mahottari district in southern Nepal. A total of 2141 dengue-suspected patients were investigated by routine laboratory assays and serological and molecular techniques, including real-time quantitative polymerase chain reaction (RT-qPCR). Among them, 455 (21.3%) were confirmed as dengue cases. The majority of dengue cases (435, 95.6%) had a primary dengue infection. The total bilirubin level was significantly higher in secondary dengue infection than in primary (

Indexed as

DengueDengue VirusSerogroupAdolescentAdultAgedAntibodies, ViralChildChild, PreschoolCross-Sectional StudiesDisease OutbreaksFemaleHumansInfantMaleMiddle AgedAntibodies, ViraldengueDENV serotypeepidemiologyNepaloutbreaksurveillanceviral load

Identifiers

PMID40732687
PMCPMC12299309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.